Prostate cancer
Conditions
Interventions
Index test:urine multiomics diagnostic model
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. People with indications of prostate cancer biopsy, including those with abnormal PSA (PSA=4ng/mL); 2. Age >=18 years old; 3. Understand and accept the meaning of the research; 4. Be able to provide urine sample >=100mL prior to biopsy; 5. Sign informed consent approved by the Ethics Committee (EC); 6. Agree to provide the results of prostate cancer biopsy or surgical pathology;
Exclusion criteria
Exclusion criteria: 1. Prostate biopsy was performed within 6 months; 2. The previous diagnosis of prostate cancer; 3. Prostate surgery was performed within 6 months, such as TURP (transurethral resection of the prostate); 4. Uncontrolled severe infection; 5. Taking drugs or hormones that affect PSA levels in the 3-6 months prior to enrollment; 6. Any conditions that the investigator believes may increase the risk to the subjects or interfere with the execution of the clinical trial; 7. Incomplete samples and clinical data;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity; | — |
Countries
China
Contacts
Public ContactDingwei Ye
Fudan University Shanghai Cancer Center
Outcome results
None listed